The executive control of attention differentiates patients with schizophrenia, their first-degree relatives and healthy controls
Florence Breton(Hôpital Louis-Mourier), Caroline Dubertret(Sulzer (United Kingdom)), Philip Gorwood(Inserm), Aurélie Planté(Inserm), J. Adès(Centre National de la Recherche Scientifique), Nicolás Ramoz(Inserm), C. Legauffre(Hôpital Louis-Mourier), Nastassja Morel(Inserm)
Cited by 70
Related Papers
How mental health care should change as a consequence of the COVID-19 pandemic
|The Lancet Psychiatry|2020|1.9k
Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy
|Nature Reviews Drug Discovery|2012|1.3k
The consequences of the COVID-19 pandemic on mental health and implications for clinical practice
|European Psychiatry|2020|1.2k